A carregar...
Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma
Galactose-modified selenium nanoparticles (GA-SeNPs) loading with doxorubicin (DOX) for hepatocellular carcinoma (HCC) therapy was investigated in this paper. Selenium nanoparticles (SeNPs) were modified with galactose as tumor targeting moiety to fabricate tumor-targeted delivery carrier GA-SeNPs,...
Na minha lista:
| Publicado no: | Drug Deliv |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327939/ https://ncbi.nlm.nih.gov/pubmed/31928356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1556359 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|